NL-OMON24781
Other
Not Applicable
Tackling the effect of duloxetine on brain function in mood specific emotional processing in healthy volunteers: An fMRI study bridging pharmacotherapeutical and cognitive psychological approaches to depression
Radboud University Nijmegen Medical Centre0 sites24 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Radboud University Nijmegen Medical Centre
- Enrollment
- 24
- Status
- Other
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Subjects must be at least 18 but not older than 50 years of age.
- •2\. Subjects must have given a written informed consent.
Exclusion Criteria
- •1\. Known hypersensitivity to duloxetine or any of the inactive ingredients.
- •2\. Contra\-indications for duloxetine (hepatic impairment, severe renal impairment with a GFR \< 30ml/min)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
the effect of duloxetine on theanxiety and depression of patients with diabetic neuropathyCondition 1: Effect of Duloxetine on the Mental State of Patients (Anxiety) with Diabetic Neuropathy. Condition 2: Effect of Duloxetine on the Mental State of Patients (Depression) with Diabetic Neuropathy.Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathyE08.43IRCT20210725051977N2Islamic Azad University30
Completed
Not Applicable
Assessment of Cognitive Functioning Before and After Treatment With DuloxetineMajor Depressive DisorderNCT00933439University of Texas Southwestern Medical Center30
Recruiting
Not Applicable
Investigation on the effects of duloxetine on depressive symptoms and sleep disturbancesmajor depressionJPRN-UMIN000006386Department of Neuropsychiatry, Kagawa University School of Medicine30
Completed
Not Applicable
Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks TrialMajor Depressive DisorderNCT03121573Taichung Veterans General Hospital30
Completed
Phase 4
Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort SyndromeMajor Depressive DisorderSoft Tissue Discomfort SyndromePainNCT01035073University of Pennsylvania22